Health behaviors and depressive symptoms in testicular cancer survivors
- PMID: 17445663
- PMCID: PMC2674069
- DOI: 10.1016/j.urology.2006.12.022
Health behaviors and depressive symptoms in testicular cancer survivors
Abstract
Objectives: Testicular cancer has one of the highest 5-year survival rates of all cancer sites. The survival period is marked by an increased risk of secondary cancer and cardiovascular events owing to treatment-related toxicities. The purposes of this cross-sectional study were to determine the prevalence of health behaviors and depressive symptoms and to assess the relationship between depression and health behaviors in survivors of testicular cancer.
Methods: A total of 162 survivors of testicular cancer 2 to 10 years after their diagnosis completed a one-time telephone interview. The interview included a battery of questions from the Behavioral Risk Factor Surveillance System assessing health behaviors (smoking, physical activity, cholesterol screening, colorectal cancer screening, alcohol consumption, and fruit and vegetable intake) and the Centers for Epidemiological Studies-Depression (CES-D) questionnaire assessing depressive symptoms.
Results: The interviews revealed a low prevalence of positive health behaviors among survivors of testicular cancer. The percentage (17.5%) of survivors of testicular cancer who scored above the cutoff on the CES-D was greater than that (11%) of large-scale population-based estimates in men aged 19 to 44 years. Smoking was significantly related to depression. Depressive symptoms (CES-D score) differed significantly depending on smoking status (current smokers, mean = 15.2; former smokers, mean = 6.2, P <0.001; and never smokers, mean = 8.7, P <0.001).
Conclusions: Given the increased risk of cancer and treatment-related morbidities of these survivors, the findings of this study suggest that healthcare professionals should encourage survivors of testicular cancer to engage in positive health behaviors and check for depressive symptoms.
Conflict of interest statement
None
References
-
- Society AC. Cancer Facts & Figures 2004. Atlanta: American Cancer Society, Inc.; 2004.
-
- Travis L, Curtis R, Storm H, Hall P, Holowaty E, Van Leeuwen F, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. Journal of the National Cancer Institute. 1997;89(19):1429–39. - PubMed
-
- Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. Journal of Clinical Oncology. 2003;21(8):1513–23. - PubMed
-
- Meinardi M, Gietema J, van der Graaf W, van Veldhuisen D, Runne M, Sluiter W, et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. Journal of Clinical Oncology. 2000;18:1725–32. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
